The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population

Current Medical Research and Opinion

Volumn 20, Issue 5, 2004, Pages 607-617

  Rosen, Raymond O ^a   Fisher, William A ^b   Eardley, Ian ^c   Niederberger, Craig ^d   Nadel, Andrea ^e   Sand, Michael ^e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e BAYER CORPORATION   (United States)

Author keywords

Epidemiology; Erectile dysfunction; Prevalence; Treatment seeking

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTITUDE; BRAZIL; CARDIOVASCULAR DISEASE; COMORBIDITY; CONSULTATION; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; MEXICO; POPULATION RESEARCH; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SPAIN; UNITED KINGDOM; UNITED STATES;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; COMORBIDITY; EUROPE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; NORTH AMERICA; PHOSPHODIESTERASE INHIBITORS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOUTH AMERICA;

EID: 2542438558     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125003467     Document Type: Article

References (37)

1. NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. J Am Med Assoc 1993;270:83-90
2. Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Br J Urol Int 1999;84:50-6
3. Akkus E, Kadioglu A, Esen A, et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002;41:298-304
4. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000;12:305-11
5. Chew KK, Earle CM, Stuckey BG, Jamrozik K, Keogh EJ. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000;12:41-5
6. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61
7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc 1999;281:537-44
8. Mak R, De Backer G, Kornitzer M, De Meyer JM. Prevalence and correlates of erectile dysfunction in a population-based study in Belgium. Eur Urol 2002;41:132-8
9. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001;166:569-74 [discussion 574-5]
10. Marumo K, Nakashima J, Murai M. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol 2001;8:53-9
11. Moreira Jr. ED, Abdo CH, Torres EB, Lobo CF, Fittipaldi JA. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001;58:583-8
12. Moreira Jr. ED, Lisboa Lobo CF, Villa M, Nicolosi A, Glasser DB. Prevalence and correlates of erectile dysfunction in Salvador, northeastern Brazil: a population-based study. Int J Impot Res 2002;14:S3-S9
13. Morillo LE, Diaz J, Estevez E, et al. Prevalence of erectile dysfunction in Colombia, Ecuador, and Venezuela: a population-based study (DENSA). Int J Impot Res 2002;14:S10-S18.
14. Nicolosi A, Moreira ED, Shirai M, Ismail Bin Mohd Tambi M, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003;61:201-6
15. Pinnock CB, Stapleton AM, Marshall VR. Erectile dysfunction in the community: a prevalence study. Med J Aust 1999;171:353-7
16. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000;30:328-38
17. Catania JA, Coates TJ, Stall R, et al. Prevalence of AIDS-related risk factors and condom use in the United States. Science 1992;258:1101-6
18. Meuleman EJ, Donkers LH, Robertson C, Keech M, Boyle P, Kiemeney LA. Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study. Ned Tijdschr Geneeskd 2001;145:576-81
19. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002;25:1458-63
20. Ledda A. Diabetes, hypertension and erectile dysfunction. Curr Med Res Opin 2000;16:s17-s20
21. Kloner RA. Hypertension as a risk for erectile dysfunction: implications for sildenafil use. J Clin Hypertens (Greenwich) 2000;2:33-6
22. Burchardt M, Burchardt T, Anastasiadis AG, et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 2001;13:276-81
23. Marumo K, Murai M. Aging and erectile dysfunction: the role of aging and concomitant chronic illness. Int J Urol 2001;8:S50-S57
24. Nurnberg HG, Seidman SN, Gelenberg AJ, Fava M, Rosen R, Shabsigh R. Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra(R)) in treated and untreated patients with depression. Urology 2002;60:58-66
25. Marumo K, Murai M. Aging and erectile dysfunction. Nippon Rinsho 2002;60:207-10
26. De Berardis G, Franciosi M, Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 2002;25:284-91
27. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JL. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res 2002;14:422-32
28. Kleinman KP, Feldman HA, Johannes CB, Derby CA, McKinlay JB. A new surrogate variable for erectile dysfunction status in the Massachusetts male aging study. J Clin Epidemiol 2000;53:71-8
29. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998;60:458-65
30. Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994;140:930-7
31. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997;9:141-8
32. Skaer TL, Sclar DA, Robinson LM, Galin RS. Trends in the rate of self-report and diagnosis of erectile dysfunction in the United States 1990-1998. Dis Manage Health Outcomes 2001;9:33-41
33. Clark AL, Wallin P. The accuracy of husbands' and wives' reports of the frequency of marital coitus. Population Studies 1964;18:165-73
34. Jacobson NS, Moore D. Spouses as observers of the events in their relationship. J Consult Clin Psychol 1981;49:269-77
35. Turner CF, Danella RD, Rogers SM. Sexual behavior in the United States 1930-1990: trends and methodological problems. Sex Transm Dis 1995;22:173-90
36. Catania JA, Gibson DR, Chitwood DD, Coates TJ. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull 1990;108:339-62
37. Turner CF, Lessler JT, Gfroerer JC. Future directions for research and practice. In: Turner CF, Lessler, JT, Gfroerer, JC, editors. Survey measurement of drug use: methodological studies. Washington, DC: US Government Printing Office; 1992